top of page


Ali Haider
Co-Founder & CEO

Ali Haider is Co-Founder & CEO of Lilia Biotechnology LLC, an early-stage AI-powered drug discovery company. The science behind Lilia Biotech was developed in a Nobel Prize-winning laboratory and is a proprietary platform technology unleashing the power of AI synergistically with novel proteomics. Previously, Ali was a medical student at Texas A&M University College of Medicine. During medical school he performed research fellowships in clinical and translational oncology at the University of Texas M.D. Anderson Cancer Center (the US News ranked #1 cancer hospital in America) and the University of Toronto's Hospital for Sick Children (ranked by Newsweek as one of the top 2 children's hospitals in the world). Ali's personal experience dealing with a medical condition while in medical school profoundly impacted his career trajectory and drove him towards pursuing transformative change in medicine at a greater scale. His achievements include over 80 peer-reviewed scientific publications, multiple national research grant awards, editorial roles at leading scientific journals including the Journal of Neurosurgery and Journal of Neuro-Oncology, and national leadership positions in organizations such as the American Association of Neurological Surgeons. In addition, Ali brings his own personal network of world-class biotech industry leaders, physicians, and scientists to contribute to the success of Lilia Biotech. He holds an Honors BS in Biology from the University of Texas at Arlington, from which he graduated magna cum laude at age 20 with nearly a dozen merit awards/scholarships fully covering his college tuition and was elected by his fellow students as President of the Honors College (consisting of over 600 student members).

Kishore Balasubramanian, MS
Director of Operations

Kishore is a 3rd year medical student in the Medical Scholar Research Pathway Program at Texas A&M University College of Medicine interested in biotechnology entrepreneurship. He has 15 peer-reviewed scientific publications and 20 abstract presentations. He holds a MS in Medical Sciences from the University of North Texas Health Science Center and graduated cum laude with a BS in Healthcare Management from the University of Texas at Dallas, where he was awarded a full-tuition Academic Excellence Scholarship.

Kate Cho, MS

Kate is a PhD student in the Cancer Biology Program at the University of Texas M.D. Anderson Cancer Center UT Health Houston Graduate School of Biomedical Sciences. Her research interests are in 3D chromatin organization and brain tumor epigenomics. She has published her scientific work on oncogene activation in Nature, one of the highest impact and most prestigious scientific journals in the world. She holds a Master of Science from Johns Hopkins University and completed her Bachelor of Science from the University of California San Diego.

Aditya Dutta Gupta

Aditya is a MD/PhD student at Texas A&M and the Houston Methodist Neurological Institute developing novel gene therapies for neurodegenerative disorders. He is interested in a career as a neurosurgeon-scientist and in performing impactful translational neuroscience research to advance patient care. He holds a BS in Biomedical Engineering from the University of Southern California, where he was awarded a full tuition USC Trustee Merit Scholarship. He attended Tracy High School in Tracy, California and graduated as Valedictorian.

Taimur Hassan, MPH, MBA
Strategy Consultant

Taimur Hassan is a medical student at Texas A&M interested in clinical innovation and neuro-oncology research. With his interdisciplinary expertise, Taimur provides valuable insight to Lilia Biotech’s development strategy in becoming the leader for precision drug discovery. He holds a MPH in Epidemiology from the University of Texas Health Science Center at Houston and a MBA from Texas A&M University Mays Business School.

Ellie Kim
Analyst Intern

Ellie Kim is an undergraduate student at the University of Texas at Austin pursuing a dual BS in Neuroscience and BA in Government. For her excellence as an undergraduate, she has won 9 competitive academic scholarships/awards. This includes the prestigious Cancer Prevention & Research Institute of Texas (CPRIT) Research Training Award for her computational genomics study of the 3D genome architecture in human brain tumors at the University of Texas M.D. Anderson Cancer Center.

Screenshot 2023-11-12 at 4.58.52 PM.png
Sruthi Ranganathan

Sruthi Ranganathan is a medical student at the University of Cambridge. She has engaged in research involving healthcare disparities and computational biology with faculty from a wide range of institutions. Beyond her academic work, Sruthi is also committed to advancing cancer research and in accelerating discoveries to the clinic.

Tarik Shihabeddin
Scientific Consultant

Tarik Shihabeddin is a PhD student in biomedical engineering at the University of Texas at Dallas/University of Texas at Southwestern Medical Center. He graduated summa cum laude with an Honors Bachelor of Science in Biology from the University of Texas at Arlington, which he attended with a full-tuition academic merit scholarship. He is passionate about advancing science and technology towards helping patient quality of life.


Raymond Sawaya, MD
Scientific Advisor

Dr. Sawaya is Emeritus Professor of Neurosurgery and was the Founding Chairman of the Department of Neurosurgery at the University of Texas M.D. Anderson Cancer Center. He is a founding figure of the specialty of neurosurgical oncology and an internationally recognized pioneer in cancer care. He has been recognized by his peers with numerous accolades, including the creation of the Raymond Sawaya Award by the American Association of Neurological Surgeons and the Raymond Sawaya Distinguished University Chair in Neurosurgery at the University of Texas M.D. Anderson Cancer Center.

Jason Sheehan, MD, PhD
Scientific Advisor

Dr. Sheehan is the Harrison Distinguished Chair of Neurosurgery and Professor of Neurological Surgery, Radiation Oncology, Biomedical Engineering, and Neuroscience at the University of Virginia. He is a global leader in clinical oncology and is passionate about purposeful innovation to improve patient outcomes. He has over 550 scientific publications and dozens of books/invited papers. He is Editor-in-Chief of the Journal of Neuro-Oncology and President of the International Radiosurgery Research Foundation.


Aaron Cohen-Gadol, MD, MS, MBA
Board Member

Dr. Aaron Cohen-Gadol is an internationally recognized neurosurgeon, scientist, inventor, and healthcare entrepreneur. He is Founder of The Neurosurgical Atlas, the world’s largest neurosurgical education software platform with over 70,000 members and an average of 3,000 active users per day. He is the Stead Family Chair in Neurosurgery, Professor of Neurosurgery, and Director of Neurosurgical Oncology at Indiana University Health. Dr. Cohen is the recipient of the Vilhelm Magnus Medal, referred to as the "Nobel Prize in neurosurgery" from the Scandinavian Neurosurgical Association for his innovative and pioneering efforts in advancing neurosurgical techniques and outcomes worldwide. Dr. Cohen's surgical success stories have been featured on CNN's "The Situation Room with Wolf Blitzer," CBS’ "The Doctors" and many others television events. Dr. Cohen has over 500 peer-reviewed scientific publications in clinical and translational neuroscience and is Associate Editor of Neurosurgical Focus. Dr. Cohen completed his residency training in neurosurgery at The Mayo Clinic in Rochester, Minnesota. He also completed advanced fellowship training in two subspecialties: epilepsy surgery at Yale University and skull base/cerebrovascular surgery at the University of Arkansas. He also attained a MS in clinical research from the Mayo Clinic Graduate School and completed his MBA from the Kelley School of Business at Indiana University. He obtained his MD with Highest Distinction from the University of Southern California and his BA in Biomedical Engineering from the University of California San Diego.


Harry Ross, MD
Board Member

Dr. Harry Ross received his medical degree (MD) from Oregon Health Sciences University in 1991, and then went on to complete both surgical internship and residency in Emergency Medicine at Hennepin County Medical Center before obtaining Emergency Medicine Board Certification. Besides being a physician, he has over 20 years of experience as a biotech executive and corporate investor. He has co-founded numerous medical device and pharmaceutical companies including Cymbidium Medical, Vertos Medical, and RxKinetix, for which he was awarded Colorado Biotech company of the year. He also served as Managing Partner at Aweida Ventures, a venture capital firm based in the Greater Denver area where he specialized in Health Science investments. In addition to numerous corporate Boards, he has also served on advisory Boards at the University of Colorado Tech Transfer, University of Colorado Medical Center, Colorado School of Mines, and Children’s Hospital of Colorado.

Screenshot 2023-06-18 at 10.59.15 PM.png
Donald Schomer, MD, MBA, MSME
Board Member

Dr. Donald Schomer is a Venture Advisor at Mercury Fund, a board-certified neuroradiologist, inventor/engineer, and health system leader in cancer imaging. He is Professor and past Chairman of the Department of Neuroradiology at the University of Texas MD Anderson Cancer Center. He holds several patents and has founded multiple medical device, biotech, and technology companies that have been successfully acquired. Dr. Schomer went to medical school and performed his residency in diagnostic radiology at the University of Texas Health Science Center at San Antonio. He then completed a clinical fellowship in neuroradiology at Stanford University School of Medicine. He attended Rice University from where he received his MBA, and the University of Houston where he received his MSME in Mechanical Engineering and BS in Biophysics.

bottom of page